Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Sales | 562 | 381 | 14 | 320 | 250 |
Gross Profit | 562 | 381 | 14 | 320 | 250 |
Operating Expenses | 4,409 | 3,530 | 3,689 | 3,842 | 3,901 |
Operating Income | -3,847 | -3,150 | -3,675 | -3,523 | -3,652 |
Other Income | 377 | 340 | 232 | 318 | 393 |
Pre-tax Income | -3,470 | -2,810 | -3,443 | -3,205 | -3,259 |
Net Income Continuous | -3,470 | -2,810 | -3,443 | -3,205 | -3,259 |
Net Income | $-3,470 | $-2,810 | $-3,443 | $-3,205 | $-3,259 |
EPS Basic Total Ops | -0.58 | -0.67 | -0.88 | -0.86 | -0.87 |
EPS Basic Continuous Ops | -0.58 | -0.67 | -0.87 | -0.86 | -0.87 |
EPS Diluted Total Ops | -0.58 | -0.67 | -0.88 | -0.86 | -0.87 |
EPS Diluted Continuous Ops | -0.58 | -0.67 | -0.87 | -0.86 | -0.87 |
EPS Diluted Before Non-Recurring Items | -0.58 | -0.67 | -0.92 | -0.86 | -0.87 |
EBITDA(a) | $-3,842 | $-3,144 | $-3,670 | $-3,521 | $-3,652 |